AVCT Related Analyst Ratings
-
Needham Research Downgrades Avocent (AVCT) to Hold
-
Ladenburg Thalmann Raises Price Target for Avocent (AVCT); Maintains 'Buy' Rating
-
Ladenburg Thalmann Initiates Coverage on Avocent (AVCT) with a Buy
-
Kaufman Bros. Resumes Coverage on Avocent (AVCT) with a Hold
-
Matrix Lighthouse Rating Changes 10/16
-
Matrix USA Rating Changes 7/24
-
ThinkPanmure Downgrades Avocent (AVCT) to Accumulate
-
J.P. Morgan Upgrades Avocent (AVCT) to Neutral
-
Matrix USA Rating Changes 4/21
-
RBC Capital Downgrades Avocent (AVCT) to Sector Perform
-
Matrix USA Rating Changes 1/08
-
Needham & Co Upgrades Avocent (AVCT) to Buy
-
Matrix USA Rating Changes 1/03
-
Matrix USA Rating Changes 12/24
-
Matrix USA Rating Changes 12/19
-
Needham & Co Initiates Coverage on Avocent (AVCT) with a Hold
-
ThinkEquity upgrades Avocent (AVCT) to Buy
-
USA Matrix Rating Changes 10/29
-
Matrix USA Rating Changes 10/10
-
ThinkEquity Starts Avocent (AVCT) at Accumulate
-
JP Morgan Starts Avocent (AVCT) at Underweight
-
Matrix USA Upgrades Avovent (AVCT) to Buy
-
ThinkEquity Starts Avocent (AVCT) at Buy
-
Baird upgrades Avocent (AVCT) to Outperform
-
Kaufman Brothers Starts Avocent (AVCT) at Buy
-
Pacific Crest Downgrades Avocent (AVCT) to Sector Perform
-
Morgan Keegan Downgrades Avocent (AVCT) to Market Perform
-
Baird dowgnrades Avocent (AVCT) to Neutral
-
WR Hambrecht Starts AVCT at Buy
-
Needham Initiates AVCT
-
Mogan Keegan Adds QLGC to Focus List; Removes AVCT
-
RBC Capital Markets Started AVCT at Outperform
-
RBC Capital Markets Started AVCT at Outperform
-
Wells Fargo Reinstated AVCT
Back to AVCT Stock Lookup
